Wednesday, June 25, 2014

Basilea Suffers U.S. Setback

The Swiss drug company said the U.S. Food and Drug Administration requires more information about its ceftobiprole pneumonia drug.



from WSJ.com: US Business http://ift.tt/Tvnii8

via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)